A common signaling abnormality of GBM is the substantial upregulation of Akt activity, typically downstream of EGFR, PDGFR or c-Met amplification, PTEN loss or activating mutations in PI3K subunits, leading to Akt activation in approximately 70% of GBMs34,35. The gene discussed is PTEN; the disease is glioblastoma.